Total trials
132
Active
23
Phase 3
5
Total enrollment
7,564
Pipeline matrix
Showing 10 of 10 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Metformin Hydrochloride | — | — | — | — | — | 1 | |
| Vildagliptin 50 MG | — | — | — | — | — | 1 | |
| Prednisolone | — | — | — | — | — | 1 | |
| Cerebrolysin | — | — | — | — | — | 1 | |
| Montelukast 10 Mg Oral | — | — | — | — | — | 1 | |
| Fexofenadine | — | — | — | — | — | 1 | |
| P11-4, a self-assembling peptide | — | — | — | — | — | 1 | |
| P11-4, a self-assembling peptide with flouride | — | — | — | — | — | 1 | |
| resin infilteration | — | — | — | — | — | 1 | |
| Chitosan Phonophresis | — | — | — | — | — | 1 |
Next readouts
- 2024-09-30
- 2025-02
- 2025-12
- 2025-12-01
- 2026-01
- 2027-05
Top conditions
- Stroke8
- Low Back Pain4
- Carpal Tunnel Syndrome3
- Rehabilitation3
- Cervical Radiculopathy3
- Oral Lichen Planus2
- Endodontic Disease2
- Fibromyalgia2
Frequently asked questions about October 6 University
- How many clinical trials does October 6 University have on ClinicalTrials.gov?
- October 6 University is listed as the lead sponsor on 132 clinical trials in ClinicalTrials.gov, 23 of which are currently active (recruiting, enrolling, or ongoing).
- How many of October 6 University's trials are in Phase 3?
- 5 of October 6 University's trials are in Phase 3, spread across 10 active drug programs.
- What therapeutic areas does October 6 University focus on?
- October 6 University's most-studied conditions on ClinicalTrials.gov are Stroke, Low Back Pain, Carpal Tunnel Syndrome, Rehabilitation, Cervical Radiculopathy.
- When are October 6 University's next clinical trial readouts?
- October 6 University has 6 upcoming primary-completion readouts tracked here; the soonest is “Chitosan Phonophresis on Cervical IN Smartphone Addicted Users”, expected around 2024-09-30.